Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.630
-0.001 (-0.06%)
May 13, 2025, 4:00 PM - Market closed
Minerva Neurosciences Employees
Minerva Neurosciences had 8 employees as of December 31, 2024. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
$781,837
Market Cap
11.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NERV News
- 1 day ago - Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 months ago - Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - US FDA declines to approve Minerva Neurosciences' schizophrenia drug - Reuters
- 1 year ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates - GlobeNewsWire
- 1 year ago - Minerva Neurosciences: There's Probably Time For One More Rally - Seeking Alpha